What is the Global market size of the Viral Clearance Market?

Global Viral Clearance Market size was valued at USD 492.9 billion in 2021 and is poised to grow from USD 535.6 billion in 2022 to USD 1519.7 billion by 2030, growing at a CAGR of 16.1% in the forecast period (2023-2030).

What is the key driver of the Global Viral Clearance Market?

The product safety procedures include the assessment of viral safety. Particularly for IND and BLA approvals, regulatory bodies place a strong emphasis on viral safety and demand high-quality data in support. Expertise in the key areas of these processes, and familiarity with the regulatory requirements and the process itself are crucial for strategic planning and can result in time, effort, and financial savings.

Viral Clearance Market Size, Share, Growth Analysis, By Type(Viral Removal Method, Viral Inactivation Method, Viral Detection Method), By Application(Recombinant Proteins, Blood, Blood Products, Vaccines), By End User(Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Others), By Method(Viral Removal Method, Viral Inactivation Method, Viral Detection Method), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2288 | Region: Global | Published Date: February, 2024
Pages: 260 | Tables: 120 | Figures: 77

Viral Clearance Market Insights

Viral Clearance Market size was valued at USD 492.9 billion in 2019 and is poised to grow from USD 535.6 billion in 2023 to USD 1519.7 billion by 2031, growing at a CAGR of 16.1% in the forecast period (2024-2031).

Viral clearance is the process of removal of viral particles and TSE (Transmissible spongiform encephalopathy) agents from the manufacturing process of development for monoclonal antibodies, recombinant proteins and glycoproteins, tissue, blood-derived products, and medical devices as these products are at risk from bacteria, chemical impurities, fungi, and from viruses. Viral contamination can affect cell culture processes, raw materials, bioreactor contamination, and downstream processing which in turn creates demand for viral safety practices. Increasing investments in the field of pharmaceutical and biotechnology and the rising demand for vaccines and other biotherapeutic agents are driving the market in the upcoming years.

US Viral Clearance Market is poised to grow at a sustainable CAGR for the next forecast year.

Viral Clearance Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The key players in the viral clearance market are working on continuous innovation in the field of research and development and product portfolio enhancement for better therapeutic outcomes for consumers. For example, In November 2021, Wuxi biologics announced the official opening of its advanced therapies testing facility, including 140,000 sq. ft laboratories to enhance the company’s Contract Testing, Developing, and manufacturing Organization businesses to meet the increasing needs of customers in cell and gene therapy industry. Companies are also focusing on mergers and acquisitions to expand their businesses. 'Charles River Laboratories International, Inc.', 'Merck KGaA', 'Wuxi AppTec Inc.', 'Eurofins Scientific', 'Avance Biosciences Inc.', 'Lonza Group AG', 'Sigma-Aldrich Corporation', 'Sartorius AG', 'Texcell, Inc.', 'Kedrion Biopharma Inc.', 'ViruSure GmbH', 'Clean Cells Inc.', 'Cytovance Biologics Inc.', 'GE Healthcare Life Sciences', 'Vironova AB', 'F. Hoffmann-La Roche Ltd.', 'BSL Bioservice Scientific Laboratories GmbH', 'Nelson Laboratories LLC', 'BioReliance Corporation', 'Novartis AG'

Growing Demand for Generics and Biosimilars: Increasing demand for biosimilars and generics is an ongoing trend. The need for sophisticated and cheap therapies for chronic diseases around the world is driving demand for recombinant non-glycosylation proteins in the biosimilars market; the application of cutting-edge technology to increase avenues.

In 2022, North America dominated the market by accounting for over 35% of the market share owing to the rapidly growing innovation in biotechnology and Life sciences. Growth of pharmaceuticals, increase in number of drug approvals, investments in research and development, and accuracy and flexibility of method in life sciences research has shaped the market growth in these areas. The growing prevalence of illnesses and an increased production of monoclonal antibodies, and government assistance for medication development are some of the primary reasons driving the viral clearance industry in the US with increasing pharmaceutical production supporting the growth of the region. Europe is expected to follow North America due to the strong foundation of research and development and pharmaceuticals and is expected to capture the second-largest share of the market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Viral Clearance Market Insights

Viral Clearance Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Viral Clearance Market?

Who are the key vendors in the Viral Clearance Market?

What is the key driver of Viral Clearance Market?

What is the key market trend for Viral Clearance Market?

Which region accounted for the largest share in Viral Clearance Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300